Healthcare - Biotechnology - NASDAQ - DE
$ 99.72
-3.71 %
$ 25.7 B
Market Cap
-51.94
P/E
INCOME STATEMENT
3.82 B
REVENUE
690 M
OPERATING INCOME
1.19 B
NET INCOME
EFFICIENCY
Earnings Waterfall
BioNTech SE
| Revenue | 3.82 B |
| Cost Of Revenue | 600 M |
| Gross Profit | 3.22 B |
| Operating Expenses | 2.53 B |
| Operating Income | 690 M |
| Other Expenses | -496 M |
| Net Income | 1.19 B |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 3 819.0 | 17 310.6 | 18 976.7 | 482.3 | 108.6 | 127.6 | 61.6 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 599.8 | 4 532.0 | 3 860.7 | 704.4 | 243.8 | 156.7 | 94.8 |
| Gross Profit | 3 219.2 | 12 778.6 | 15 116.0 | (222.0) | (135.2) | (29.2) | (33.2) |
| OPERATING INCOME | |||||||
| Operating Expenses | 2 528.8 | 135.9 | 200.1 | (139.6) | 46.3 | 24.7 | 28.1 |
| Selling, General and Administrative Expenses | 557.7 | 544.2 | 328.9 | 108.6 | 43.4 | 27.1 | 29.5 |
| Research and Development Expenses | 1 783.1 | 116.0 | 102.7 | 645.0 | 226.5 | 143.0 | 85.5 |
| Operating Income | 690.4 | 12 642.7 | 15 283.8 | (82.4) | (181.5) | (53.9) | (61.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 7.9 | 18.9 | 5.4 | 64.9 | 1.7 | 1.7 | 0.7 |
| Total Other Income | 495.7 | 311.4 | (237.4) | (63.4) | 2.1 | 6.2 | (24.6) |
| Pre-Tax Income | 1 186.1 | 12 954.1 | 15 046.4 | (145.8) | (179.4) | (47.7) | (85.9) |
| NET INCOME | |||||||
| Tax Provision | 255.8 | 3 519.7 | 4 753.9 | (161.0) | (0.3) | 0.6 | 45 K |
| Net Income | 930.3 | 9 434.4 | 10 292.5 | 15.2 | (179.2) | (48.0) | (85.7) |
| EPS | 3.83 | 38.1 | 43.9 | 0.0602 | 0.85 | 0.21 | 0.38 |